West Pharmaceutical Services (WST) Receivables - Other (2017 - 2025)
West Pharmaceutical Services' Receivables - Other history spans 9 years, with the latest figure at $11.9 million for Q4 2025.
- For Q4 2025, Receivables - Other fell 48.93% year-over-year to $11.9 million; the TTM value through Dec 2025 reached $11.9 million, down 48.93%, while the annual FY2025 figure was $11.9 million, 48.93% down from the prior year.
- Receivables - Other for Q4 2025 was $11.9 million at West Pharmaceutical Services, down from $27.5 million in the prior quarter.
- Across five years, Receivables - Other topped out at $42.3 million in Q3 2024 and bottomed at $10.1 million in Q2 2021.
- The 5-year median for Receivables - Other is $19.6 million (2023), against an average of $19.9 million.
- The largest annual shift saw Receivables - Other surged 112.56% in 2024 before it tumbled 48.93% in 2025.
- A 5-year view of Receivables - Other shows it stood at $14.6 million in 2021, then grew by 11.64% to $16.3 million in 2022, then surged by 31.9% to $21.5 million in 2023, then increased by 8.37% to $23.3 million in 2024, then crashed by 48.93% to $11.9 million in 2025.
- Per Business Quant, the three most recent readings for WST's Receivables - Other are $11.9 million (Q4 2025), $27.5 million (Q3 2025), and $27.9 million (Q2 2025).